Neoplasms, Unknown Primary

BACKGROUND Estimating the burden of healthcare-associated infections (HAIs) compared to other communicable diseases is an ongoing… (More)

Toward development of a precision medicine framework for metastatic, castration-resistant prostate cancer (mCRPC), we established… (More)

Cancer of unknown primary site (CUP) is a well recognised clinical disorder, accounting for 3-5% of all malignant epithelial… (More)

Cilia are complex structures that have garnered interest because of their roles in vertebrate development and their involvement… (More)

Unknown primary cancer (UPC) is defined by the presence of metastatic disease for which a primary site is undetectable on… (More)

Metastatic Cancer of Unknown Primary Site (CUP) accounts for approximately 3% of all malignant neoplasms and is therefore one of… (More)

[1] The global distribution of carbonaceous aerosols is simulated online in the Goddard Institute for Space Studies General… (More)

Lymphocytes were originally thought to form the basis of a ‘cancer immunosurveillance’ process that protects immunocompetent… (More)

Transforming growth factor beta 1 (TGF beta 1) is shown here to be required for yolk sac haematopoiesis and endothelial… (More)

Fluorescamine is a new reagent for the detection of primary amines in the picomole range. Its reaction with amines is almost… (More)